Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

How various drugs affect anxiety-related behavior in male and female rats prenatally exposed to methamphetamine

E. Macúchová, M. Ševčíková, I. Hrebíčková, K. Nohejlová, R. Šlamberová,

. 2016 ; 51 (-) : 1-11. [pub] 20160408

Language English Country England, Great Britain

Document type Journal Article

Grant support
NT14484 MZ0 CEP Register

Different forms of anxiety-related behavior have been reported after a single drug use of many abused substances, however, less is known about how males and females are affected differently from exposure to various drugs. Furthermore, chronic prenatal methamphetamine (MA) exposure was shown to predispose the animal to an increased sensitivity to drugs administrated in adulthood. Using the Elevated plus-maze test (EPM), the first aim of the present study was to examine how male and female rats are affected by acute drug treatment with subcutaneously (s.c.) administrated (a) MA (1mg/kg); (b) drugs with a similar mechanism of action to MA: amphetamine (AMP, 1mg/kg), cocaine (COC, 5mg/kg), 3,4-methylenedioxymethamphetamine (MDMA, 5mg/kg); and (c) drugs with different mechanisms of action: morphine (MOR, 5mg/kg), and Δ 9-tetrahydrocannabinol (THC, 2mg/kg). The second aim was to determine if prenatally MA-exposed (5mg/kg) animals show an increased sensitivity to adult drug treatment. The parameters analyzed were divided into two categories: anxiety-related behavior and anxiety-unrelated/exploratory behavior. Our results showed in female rats a decreased percentage of the time spent in the closed arms (CA) after MA, and an increased percentage of the time spent in the open arms (OA) after MA, AMP, and COC treatment, indicating an anxiolytic-like effect. In females, MDMA and THC treatment increased the percentage of the time spent in the CA. An increased percentage of the time spent in the CA was also seen after MOR treatment in females as well as in males, indicating an anxiogenic-like effect. As far as the interaction between prenatal MA exposure and adult drug treatment is concerned, there was no effect found. In conclusion, it seems that: (a) in some cases female rats are more vulnerable to acute drug treatment, in terms of either anxiogenic- or anxiolytic-like effects; (b) prenatal MA exposure does not sensitize animals to the anxiety-related effects of any of the drugs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013958
003      
CZ-PrNML
005      
20181030120555.0
007      
ta
008      
170413s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijdevneu.2016.04.001 $2 doi
035    __
$a (PubMed)27067624
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Macúchová, Eva $u Charles University in Prague, Third Faculty of Medicine, Department of Normal, Pathological and Clinical Physiology, Prague, Czech Republic. $7 xx0235047
245    10
$a How various drugs affect anxiety-related behavior in male and female rats prenatally exposed to methamphetamine / $c E. Macúchová, M. Ševčíková, I. Hrebíčková, K. Nohejlová, R. Šlamberová,
520    9_
$a Different forms of anxiety-related behavior have been reported after a single drug use of many abused substances, however, less is known about how males and females are affected differently from exposure to various drugs. Furthermore, chronic prenatal methamphetamine (MA) exposure was shown to predispose the animal to an increased sensitivity to drugs administrated in adulthood. Using the Elevated plus-maze test (EPM), the first aim of the present study was to examine how male and female rats are affected by acute drug treatment with subcutaneously (s.c.) administrated (a) MA (1mg/kg); (b) drugs with a similar mechanism of action to MA: amphetamine (AMP, 1mg/kg), cocaine (COC, 5mg/kg), 3,4-methylenedioxymethamphetamine (MDMA, 5mg/kg); and (c) drugs with different mechanisms of action: morphine (MOR, 5mg/kg), and Δ 9-tetrahydrocannabinol (THC, 2mg/kg). The second aim was to determine if prenatally MA-exposed (5mg/kg) animals show an increased sensitivity to adult drug treatment. The parameters analyzed were divided into two categories: anxiety-related behavior and anxiety-unrelated/exploratory behavior. Our results showed in female rats a decreased percentage of the time spent in the closed arms (CA) after MA, and an increased percentage of the time spent in the open arms (OA) after MA, AMP, and COC treatment, indicating an anxiolytic-like effect. In females, MDMA and THC treatment increased the percentage of the time spent in the CA. An increased percentage of the time spent in the CA was also seen after MOR treatment in females as well as in males, indicating an anxiogenic-like effect. As far as the interaction between prenatal MA exposure and adult drug treatment is concerned, there was no effect found. In conclusion, it seems that: (a) in some cases female rats are more vulnerable to acute drug treatment, in terms of either anxiogenic- or anxiolytic-like effects; (b) prenatal MA exposure does not sensitize animals to the anxiety-related effects of any of the drugs.
650    _2
$a analgetika $x farmakologie $7 D000700
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a zvířata $7 D000818
650    _2
$a úzkost $x chemicky indukované $7 D001007
650    _2
$a stimulanty centrálního nervového systému $x toxicita $7 D000697
650    _2
$a estrální cyklus $x účinky léků $7 D030762
650    _2
$a pátrací chování $x účinky léků $7 D005106
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a bludiště - učení $x účinky léků $7 D018782
650    _2
$a methamfetamin $x toxicita $7 D008694
650    _2
$a N-methyl-3,4-methylendioxyamfetamin $x farmakologie $7 D018817
650    _2
$a těhotenství $7 D011247
650    _2
$a zpožděný efekt prenatální expozice $x chemicky indukované $x patofyziologie $7 D011297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a serotoninové látky $x farmakologie $7 D018490
650    _2
$a sexuální faktory $7 D012737
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ševčíková, Mária $u Charles University in Prague, Third Faculty of Medicine, Department of Normal, Pathological and Clinical Physiology, Prague, Czech Republic. $7 xx0214442
700    1_
$a Hřebíčková, Ivana $u Charles University in Prague, Third Faculty of Medicine, Department of Normal, Pathological and Clinical Physiology, Prague, Czech Republic. $7 xx0280681
700    1_
$a Nohejlová, Kateryna $u Charles University in Prague, Third Faculty of Medicine, Department of Normal, Pathological and Clinical Physiology, Prague, Czech Republic. $7 mzk2013788463
700    1_
$a Šlamberová, Romana $u Charles University in Prague, Third Faculty of Medicine, Department of Normal, Pathological and Clinical Physiology, Prague, Czech Republic. Electronic address: romana.slamberova@lf3.cuni.cz. $7 xx0052834
773    0_
$w MED00002312 $t International journal of developmental neuroscience the official journal of the International Society for Developmental Neuroscience $x 1873-474X $g Roč. 51, č. - (2016), s. 1-11
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27067624 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20181030121111 $b ABA008
999    __
$a ok $b bmc $g 1200423 $s 974736
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 51 $c - $d 1-11 $e 20160408 $i 1873-474X $m International journal of developmental neuroscience $n Int J Dev Neurosci $x MED00002312
GRA    __
$a NT14484 $p MZ0
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...